Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 521065, 10 pages
http://dx.doi.org/10.1155/2014/521065
Research Article

Protective Effects of Tualang Honey against Oxidative Stress and Anxiety-Like Behaviour in Stressed Ovariectomized Rats

1Institute of Health Sciences, Muscat, Ruwi, P.O. Box 3720, Code 112, Oman
2Department of Physiology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Malaysia
3Department of Psychiatry, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Malaysia
4Department of Anatomy, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Malaysia

Received 17 April 2014; Accepted 23 June 2014; Published 9 September 2014

Academic Editor: Fatima Martel

Copyright © 2014 Badriya Al-Rahbi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Harwell, “Biochemistry of oxidative stress,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1147–1150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Miquel, A. Ramírez-Boscá, J. V. Ramírez-Bosca, and J. D. Alperi, “Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants,” Archives of Gerontology and Geriatrics, vol. 42, no. 3, pp. 289–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Agarwal, S. Gupta, L. Sekhon, and R. Shah, “Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1375–1403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Sánchez-Rodríguez, M. Zacarías-Flores, A. Arronte-Rosales, E. Correa-Muñoz, and V. M. Mendoza-Núñez, “Menopause as risk factor for oxidative stress,” Menopause, vol. 19, no. 3, pp. 361–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Halliwell, “Oxidative stress and neurodegeneration: where are we now?” Journal of Neurochemistry, vol. 97, no. 6, pp. 1634–1658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Reynolds, C. Laurie, R. Lee Mosley, and H. E. Gendelman, “Oxidative stress and the pathogenesis of neurodegenerative disorders,” International Review of Neurobiology, vol. 82, pp. 297–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Ng, M. Berk, O. Dean, and A. I. Bush, “Oxidative stress in psychiatric disorders: evidence base and therapeutic implications,” International Journal of Neuropsychopharmacology, vol. 11, no. 6, pp. 851–876, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Bouayed, H. Rammal, and R. Soulimani, “Oxidative stress and anxiety Relationship and cellular pathways,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 2, pp. 63–67, 2009. View at Google Scholar · View at Scopus
  9. I. Hovatta, J. Juhila, and J. Donner, “Oxidative stress in anxiety and comorbid disorders,” Neuroscience Research, vol. 68, no. 4, pp. 261–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Bouayed, H. Rammal, and R. Soulimani, “Oxidative stress and anxiety: relationship and cellular pathways,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 2, pp. 63–67, 2009. View at Google Scholar · View at Scopus
  11. J. Bouayed, “Polyphenols: a potential new strategy for the prevention and treatment of anxiety and depression,” Current Nutrition and Food Science, vol. 6, no. 1, pp. 13–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Kuloglu, M. Atmaca, E. Tezcan, B. Ustundag, and S. Bulut, “Antioxidant enzyme and malondialdehyde levels in patients with panic disorder,” Neuropsychobiology, vol. 46, no. 4, pp. 186–189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kuloglu, M. Atmaca, E. Tezcan, Ö. Gecici, H. Tunckol, and B. Ustundag, “Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder,” Neuropsychobiology, vol. 46, no. 1, pp. 27–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Al-Rahbi, R. Zakaria, Z. Othman, A. Hassan, S. Muthuraju, and W. M. Z. Wan Mohammad, “Mood and memory function in ovariectomised rats exposed to social instability stress,” BioMed Research International, vol. 2013, Article ID 493643, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. A. Frye and J. Wawrzycki, “Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats,” Hormones and Behavior, vol. 44, no. 4, pp. 319–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Hill and W. C. Boon, “Estrogens, brain, and behavior: lessons from knockout mouse models,” Seminars in Reproductive Medicine, vol. 27, no. 3, pp. 218–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. G. Nomikos and C. Spyraki, “Influence of oestrogen on spontaneous and diazepam-induced exploration of rats in an elevated plus maze,” Neuropharmacology, vol. 27, no. 7, pp. 691–696, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Frye and A. A. Walf, “Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats,” Behavioral Neuroscience, vol. 118, no. 2, pp. 306–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. L. M. Chepulis, N. J. Starkey, J. R. Waas, and P. C. Molan, “The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats,” Physiology and Behavior, vol. 97, no. 3-4, pp. 359–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. I. Khalil, N. Alam, M. Moniruzzaman, S. A. Sulaiman, and S. H. Gan, “Phenolic acid composition and antioxidant properties of malaysian honeys,” Journal of Food Science, vol. 76, no. 6, pp. C921–C928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Bashkaran, E. Zunaina, S. Bakiah, S. Sulaiman, K. Sirajudeen, and V. Naik, “Anti-inflammatory and antioxidant effects of Tualang honey in alkali injury on the eyes of rabbits : experimental animal study,” BMC Complementary and Alternative Medicine, vol. 11, article 90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Kishore, A. S. Halim, M. S. N. Syazana, and K. N. S. Sirajudeen, “Tualang honey has higher phenolic content and greater radical scavenging activity compared with other honey sources,” Nutrition Research, vol. 31, no. 4, pp. 322–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. K. Yao, S. L. A. Razak, N. Ismail et al., “Malaysian gelam honey reduces oxidative damage and modulates antioxidant enzyme activities in young and middle aged rats,” Journal of Medicinal Plant Research, vol. 5, no. 23, pp. 5618–5625, 2011. View at Google Scholar · View at Scopus
  24. O. O. Erejuwa, S. A. Sulaiman, M. S. Wahab, K. N. S. Sirajudeen, M. S. M. D. Salleh, and S. Gurtu, “Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats,” Annales d'Endocrinologie, vol. 71, no. 4, pp. 291–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. O. O. Erejuwa, S. A. Sulaiman, M. S. Wahab, K. N. S. Sirajudeen, S. Salleh, and S. Gurtu, “Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 374037, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Shafin, R. Zakaria, N. H. Nik Hussain, and Z. Othman, “Tualang honey supplementation reduces blood oxidative stress levels/activities in postmenopausal women,” ISRN Oxidative Medicine, vol. 2014, Article ID 364836, 4 pages, 2014. View at Publisher · View at Google Scholar
  27. K. Takuma, A. Matsuo, Y. Himeno et al., “17beta-estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats,” Neuroscience, vol. 146, no. 1, pp. 60–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Mohamad Zaid, S. A. Sulaiman, N. H. Othman et al., “Protective effects of Tualang honey on bone structure in experimental postmenopausal rats,” Clinics, vol. 67, no. 7, pp. 779–784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Liang, S. Pun, and T. J. Wronski, “Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats,” Endocrinology, vol. 140, no. 12, pp. 5780–5788, 1999. View at Google Scholar · View at Scopus
  30. B. G. Saruhan and M. A. Ketani, “Effects of ovariectomy and estrogen replacement on rat tongue mucosa,” İnönü Üniversitesi Tıp Fakültesi Dergisi, vol. 13, no. 3, pp. 141–145, 2006. View at Google Scholar
  31. Y. Y. Liu, W. M. Yao, T. Wu, B. L. Xu, F. Chen, and L. Cui, “Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts,” Journal of Bone and Mineral Metabolism, vol. 29, no. 2, pp. 149–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Sandoval, K. K. Ryan, A. D. de Kloet, S. C. Woods, and R. J. Seeley, “Female rats are relatively more sensitive to reduced lipid versus reduced carbohydrate availability,” Nutrition & Diabetes, vol. 2, article e27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Haller, E. Fuchs, J. Halász, and G. B. Makara, “Defeat is a major stressor in males while social instability is stressful mainly in females: Towards the development of a social stress model in female rats,” Brain Research Bulletin, vol. 50, no. 1, pp. 33–39, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Detke, M. Rickels, and I. Lucki, “Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants,” Psychopharmacology, vol. 121, no. 1, pp. 66–72, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. M. J. Detke and I. Lucki, “Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth,” Behavioural Brain Research, vol. 73, no. 1-2, pp. 43–46, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. L. A. Brotto, A. M. Barr, and B. B. Gorzalka, “Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin,” European Journal of Pharmacology, vol. 402, no. 1-2, pp. 87–93, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  38. R. E. Adamec and T. Shallow, “Lasting effects on rodent anxiety of a single exposure to a cat,” Physiology and Behavior, vol. 54, no. 1, pp. 101–109, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. R. E. Bowman, M. C. Zrull, and V. N. Luine, “Chronic restraint stress enhances radial arm maze performance in female rats,” Brain Research, vol. 904, no. 2, pp. 279–289, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. T. N. Huynh, A. M. Krigbaum, J. J. Hanna, and C. D. Conrad, “Sex differences and phase of light cycle modify chronic stress effects on anxiety and depressive-like behavior,” Behavioural Brain Research, vol. 222, no. 1, pp. 212–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. E. R. de Kloet, M. Joëls, and F. Holsboer, “Stress and the brain: from adaptation to disease,” Nature Reviews Neuroscience, vol. 6, no. 6, pp. 463–475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. J. Lupien, B. S. McEwen, M. R. Gunnar, and C. Heim, “Effects of stress throughout the lifespan on the brain, behaviour and cognition,” Nature Reviews Neuroscience, vol. 10, no. 6, pp. 434–445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Gentsch, M. Lichtsteiner, and H. Feer, “Locomotor activity, defecation score and corticosterone levels during an openfield exposure: a comparison among individually and group-housed rats, and genetically selected rat lines,” Physiology and Behavior, vol. 27, no. 1, pp. 183–186, 1981. View at Publisher · View at Google Scholar · View at Scopus
  44. M. A. Morgan and D. W. Pfaff, “Effects of estrogen on activity and fear-related behaviors in mice,” Hormones and Behavior, vol. 40, no. 4, pp. 472–482, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. I. C. Weiss, C. R. Pryce, A. L. Jongen-Rêlo, N. I. Nanz-Bahr, and J. Feldon, “Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat,” Behavioural Brain Research, vol. 152, no. 2, pp. 279–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Galeeva and P. Tuohimaa, “Analysis of mouse plus-maze behavior modulated by ovarian steroids,” Behavioural Brain Research, vol. 119, no. 1, pp. 41–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Kalandakanond-Thongsong, S. Daendee, and A. Srikiatkhachorn, “Effect of the acute and chronic estrogen on anxiety in the elevated T-maze,” Physiology & Behavior, vol. 105, no. 2, pp. 357–363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Daendee, B. Thongsong, and S. Kalandakanond-Thongsong, “Effects of time of estrogen deprivation on anxiety-like behavior and GABAA receptor plasticity in ovariectomized rats,” Behavioural Brain Research, vol. 246, pp. 86–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-J. Ho, C.-F. Wang, W.-Y. Hsu et al., “Psychoimmunological effects of dioscorea in ovariectomized rats: role of anxiety level,” Annals of General Psychiatry, vol. 6, no. 1, article 21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. T. A. Pigott, “Anxiety disorders in women,” Psychiatric Clinics of North America, vol. 26, no. 3, pp. 621–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Cloitre, K. C. Stovall-McClough, R. Miranda, and C. M. Chemtob, “Therapeutic alliance, negative mood regulation, and treatment outcome in child abuse-related posttraumatic stress disorder,” Journal of Consulting and Clinical Psychology, vol. 72, no. 3, pp. 411–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. E. M. Glover, T. Jovanovic, K. B. Mercer et al., “Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder,” Biological Psychiatry, vol. 72, no. 1, pp. 19–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. A. A. Walf and C. A. Frye, “The use of the elevated plus maze as an assay of anxiety-related behavior in rodents,” Nature Protocols, vol. 2, no. 2, pp. 322–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. A. A. Walf and C. A. Frye, “Estradiol reduces anxiety-and depression-like behavior of aged female mice,” Physiology & Behavior, vol. 99, no. 2, pp. 169–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Mora, N. Dussaubat, and G. Díaz-Véliz, “Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats,” Psychoneuroendocrinology, vol. 21, no. 7, pp. 609–620, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. U. Halbreich, “Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression,” Acta Psychiatrica Scandinavica, vol. 95, no. 3, pp. 169–176, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. F. N. Demetrio, J. Rennó Jr., A. Gianfaldoni et al., “Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women : a randomized double-blind, controlled study,” Archives of Women's Mental Health, vol. 14, no. 6, pp. 479–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Hickey, J. Elliott, and S. L. Davison, “Hormone replacement therapy,” British Medical Journal, vol. 344, article e763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Díaz-Véliz, T. Alarcón, C. Espinoza, N. Dussaubat, and S. Mora, “Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats,” Pharmacology Biochemistry and Behavior, vol. 58, no. 3, pp. 637–642, 1997. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Martínez-Mota, E. Estrada-Camarena, C. López-Rubalcava, C. M. Contreras, and A. Fernández-Guasti, “Interaction of desipramine with steroid hormones on experimental anxiety,” Psychoneuroendocrinology, vol. 25, no. 2, pp. 109–120, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Moosmann and C. Behl, “The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 8867–8872, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Al-Rahbi, R. Zakaria, Z. Othman, A. Hassan, Z. I. Mohd Ismail, and S. Muthuraju, “Tualang honey supplement improves memory performance and hippocampal morphology in stressed overiectomized rats,” Acta Histochemica, vol. 116, no. 1, pp. 79–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Mortensen, V. Breinholt, T. Dalsgaard et al., “17β-estradiol but not the phytoestrogen naringenin attenuates aortic cholesterol accumulation in WHHL rabbits,” Journal of Lipid Research, vol. 42, no. 5, pp. 834–843, 2001. View at Google Scholar · View at Scopus
  64. M. Özgönül, A. Öge, E. D. Sezer, F. Bayraktar, and E. Y. Sözmen, “The effects of estrogen and Raloxifene treatment on antioxidant enzymes in brain and liver of ovarectomized female rats,” Endocrine Research, vol. 29, no. 2, pp. 183–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Topçuoglu, H. Uzun, H. Balci et al., “Effects of estrogens on oxidative protein damage in plasma and tissues in ovariectomised rats,” Clinical and Investigative Medicine, vol. 32, no. 2, pp. E133–E143, 2009. View at Google Scholar · View at Scopus
  66. X. Zhou, A. M. Smith, M. L. Failla, K. E. Hill, and Z. Yu, “Estrogen status alters tissue distribution and metabolism of selenium in female rats,” Journal of Nutritional Biochemistry, vol. 23, no. 6, pp. 532–538, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. G. S. Ceravolo, F. P. Filgueira, T. J. Costa et al., “Conjugated equine estrogen treatment corrected the exacerbated aorta oxidative stress in ovariectomized spontaneously hypertensive rats,” Steroids, vol. 78, no. 3, pp. 341–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. T. C. Unfer, G. M. M. Conterato, J. C. N. da Silva, M. M. M. F. Duarte, and T. Emanuelli, “Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women,” Clinica Chimica Acta, vol. 369, no. 1, pp. 73–77, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Escalante Gómez and S. Quesada Mora, “HRT decreases DNA and lipid oxidation in postmenopausal women,” Climacteric, vol. 16, no. 1, pp. 104–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Petrovska, B. Dejanova, and V. Jurisic, “Estrogens: mechanisms of neuroprotective effects,” Journal of Physiology and Biochemistry, vol. 68, no. 3, pp. 455–460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Behl and D. Manthey, “Neuroprotective activities of estrogen: an update,” Journal of Neurocytology, vol. 29, no. 5-6, pp. 351–358, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Cegelski, C. V. Rice, R. D. O'Connor et al., “Mapping the locations of estradiol and potent neuroprotective analogues in phospholipid bilayers by REDOR,” Drug Development Research, vol. 66, no. 2, pp. 93–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. K. E. Gridley, P. S. Green, and J. W. Simpkins, “Low concentrations of estradiol reduce β-amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells,” Brain Research, vol. 778, no. 1, pp. 158–165, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Green, K. Gridley, and J. Simpkins, “Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione,” Neuroscience, vol. 84, no. 1, pp. 7–10, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. J. W. Simpkins, J. Wang, X. Wang, E. Perez, L. Prokai, and J. A. Dykens, “Mitochondria play a central role in estrogen-induced neuroprotection,” Current Drug Targets: CNS and Neurological Disorders, vol. 4, no. 1, pp. 69–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. V. B. C. Junqueira, S. B. M. Barros, S. S. Chan et al., “Aging and oxidative stress,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 5–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Bednarek-Tupikowska, U. Tworowska, I. Jedrychowska et al., “Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women,” Clinical Endocrinology, vol. 64, no. 4, pp. 463–468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. O. A. Oyekunle, T. P. Ogundeji, and A. K. Okojie, “Behavioral modifications related to consumption of a “soft” adaptogen, bee honey, by rats,” Neurophysiology, vol. 43, no. 1, pp. 38–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. S. K. Bhattacharya, A. Bhattacharya, K. Sairam, and S. Ghosal, “Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study,” Phytomedicine, vol. 7, no. 6, pp. 463–469, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Pereira, D. Tysca, P. Oliveira, L. F. D. S. Brum, J. N. Picada, and P. Ardenghi, “Neurobehavioral and genotoxic aspects of rosmarinic acid,” Pharmacological Research, vol. 52, no. 3, pp. 199–203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. N. G. Bowery, “GABAB receptor: a site of therapeutic benefit,” Current Opinion in Pharmacology, vol. 6, no. 1, pp. 37–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Bouayed, H. Rammal, A. Dicko, C. Younos, and R. Soulimani, “Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects,” Journal of the Neurological Sciences, vol. 262, no. 1-2, pp. 77–84, 2007. View at Publisher · View at Google Scholar · View at Scopus